Longevity, decoded.
One protocol at a time.
Discover How SkinStim Can Enhance Your Health and Beauty
Howard J. Leonhardt Named Finalist for Orange County Business Journal Innovator of the Year
Lionheart Health founder recognized for advancing bioelectric medicine, multi-organ regeneration and healthspan technologies ORANGE COUNTY, Calif....
Read moreLionheart Health Research Studies List Mid 2026
Lionheart Health Research Portfolio Mobile-friendly master table—79 programs. Second Heart Assist™ removed. Status: ✅ Results reported...
Read more
Leonhardt Ventures LLC and Lionheart Health Announce Patent Application for Bioelectric Modulation of Mitochondrial Function, Muscle Strength and Age-Related Sarcopenia
Novel platform is designed to use programmed bioelectric signaling—alone or in combination with biologics, pharmaceuticals and...
Read more
Lionheart Health Announces Planned PancreaCell™ Clinical Study Combining Refillable Cell-Therapy Delivery and Bioelectric Stimulation for Type 1 Diabetes
Investigational Lionheart Octopus™ platform is designed to combine localized regenerative-cell delivery, nutrient hydrogel support, repeatable/refillable dosing...
Read more
Praise for Xprize Healthspan on Top 20 Finalists Reveal Day
There are moments in history when the way we solve problems matters just as much as...
Read more
Lionheart Health Announces Development Initiative for Bioelectrically Paced “Living Muscle Pump” and AortaCell Regenerative Platform Inspired by New Nature Aging Myograft Research
Company plans to integrate contractile myografts, AortaCell technologies, Leonhardt pulsatile grafts, bioelectric protein-expression systems, regenerative cells...
Read more
Lionheart Health Adapts E‑Stent™ Bioelectric Platform for Vision Regeneration and Eye-Pressure Disorders
Investigational micro-implant is being designed to deliver localized bioelectric signaling in support of retinal, optic-nerve and...
Read more
Lionheart Health and Leonhardt Ventures Announce Indicative $47 Million Central Valuation of Regenerative-Medicine IP Portfolio
Analytical report estimates a $24 million to $86 million fair-market-value range and a conditional $70 million...
Read more
Lionheart Health Announces Encouraging EyeCell™ Clinical Data, Advances Macular Degeneration Program Toward Phase II Study and Launches EyeCell™ Skaphor™ for Eye-Fatigue Wellness
Preliminary multi-site EyeCell™ data show 68.8% of evaluable treated eyes improved and 87.5% improved or remained...
Read more
Lionheart Health Announces Provisional Patent Filing and New Research Program Focused on Bioelectrically Enhanced Exosomes
Company to investigate whether precisely programmed bioelectric stimulation can increase extracellular-vesicle production, optimize regenerative cargo and...
Read more
Lionheart Health and Leonhardt Ventures Announce MitoCell™ / PC-Up™ Mitochondrial Restoration Research Program and New Provisional Patent Filing
New research initiative combines phosphatidylcholine and choline support with bioelectric signaling, BodStim™, Klotho-Up™, AMPK, Sestrin and...
Read more
Lionheart Health Expands Bioelectric Regenerative Medicine Platform to Target TBX20, PITX2, MEIS1 and pro-ANP/NPPA
Company plans research program combining precisely controlled bioelectric signaling, regenerative protein-expression targets, Klotho-expressing cells and nutrient...
Read more